Sanofi – Together against COVID-19!

Updates
5 Apr 2020
Share

In the last weeks, the consumption of Doliprane has doubled. This paracetamol medication is the main treatment for those who develop a mild form of Covid-19.

Faced with rising demand and to avoid a possible shortage, the Sanofi plant in Compiègne increased its production rates.

LINK

(Source: TF1)

About AIM

AIM (Association des Industries de Marque) is the European Brands Association, which represents manufacturers of branded consumer goods in Europe on key issues that affect their ability to design, distribute and market their brands. AIM’s membership comprises 2,500 businesses ranging from SMEs to multinationals, directly or indirectly through its corporate and national association members.

Contact

Headshot
Donata Cagnato Communications Manager Contact Donata